Medicare Enrolled

Dr. Rishi Singh, MD

Ophthalmology · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
243 CHARLES ST, Boston, MA 02114
6175733288
Registered in NPPES since 2006
NPI: 1750447660 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Rishi Singh is an ophthalmology specialist in Boston, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 160 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Singh received a total of $1,660,471 from 48 pharmaceutical and/or device companies across 1029 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 160 Medicare services $1,660,471 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
160
Medicare services
Bottom 9% in MA for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
68 $17 $171
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
46 $47 $397
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $49 $272
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
21 $65 $548
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,660,471
Total received (2018-2024)
Avg $237,210/year across 7 years
Top 0% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,029
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$242,093
2023
$445,555
2022
$242,280
2021
$191,267
2020
$118,016
2019
$232,303
2018
$188,956

Payments by company (2024)

Apellis Pharmaceuticals, Inc.
$57,029
Astellas Pharma US Inc
$40,346
Regeneron Healthcare Solutions, Inc.
$31,685
Alimera Sciences, Inc.
$16,162
Genentech USA, Inc.
$15,819
EyePoint Pharmaceuticals US, Inc.
$14,024
ABBVIE INC.
$13,483
Genentech, Inc.
$10,205
Carl Zeiss Meditec, Inc.
$9,725
F. Hoffmann-La Roche AG
$9,677
Carl Zeiss Meditec USA, Inc.
$8,937
Topcon Healthcare, Inc.
$7,500
Regeneron Pharmaceuticals, Inc.
$5,540
Boehringer Ingelheim International GmbH
$975
Bausch & Lomb Americas Inc.
$353
Hoffmann-La Roche Limited
$271
Oculus Surgical Inc.
$161
Harrow Eye, LLC
$72
Janssen Pharmaceuticals, Inc
$60
Ocular Therapeutix, Inc.
$36
Actelion Pharmaceuticals US, Inc.
$31
Top 3 companies account for 53.3% of 2024 payments
All-time payments by company (2018-2024) ›
Apellis Pharmaceuticals, Inc.
$256,413
Regeneron Healthcare Solutions, Inc.
$253,711
Genentech USA, Inc.
$159,409
Alcon Vision LLC
$106,522
Novartis Pharmaceuticals Corporation
$88,090
Carl Zeiss Meditec, Inc.
$87,248
Genentech, Inc.
$85,225
EyePoint Pharmaceuticals US, Inc.
$73,522
Bausch & Lomb, a division of Bausch Health US, LLC
$61,106
Regeneron Pharmaceuticals, Inc.
$49,305
Astellas Pharma US Inc
$43,127
F. Hoffmann-La Roche AG
$41,950
Hoffmann-La Roche Limited
$40,439
Coherus Biosciences Inc.
$38,515
Novartis Pharma AG
$27,319
Alcon Laboratories Inc
$25,926
Alimera Sciences, Inc.
$24,858
ABBVIE INC.
$22,529
Roche Products Limited
$22,301
Bausch & Lomb Americas Inc.
$18,577
Ocular Therapeutix, Inc.
$16,594
NOVARTIS PHARMACEUTICALS CORPORATION
$16,196
AbbVie Inc.
$15,472
Alcon Research LLC
$14,441
Carl Zeiss Meditec USA, Inc.
$8,937
Biogen, Inc.
$8,345
Topcon Healthcare, Inc.
$7,500
Kala Pharmaceuticals, Inc.
$7,255
Aerie Pharmaceuticals, Inc.
$6,517
Kyowa Kirin, Inc.
$5,916
Ellex, Inc
$5,000
Allergan Inc.
$4,615
OPTOVUE, INC.
$4,457
Allergan, Inc.
$4,378
Optos, Inc.
$2,500
Oyster Point Pharma, Inc.
$2,142
Beaver-Visitec International, Inc.
$1,400
Boehringer Ingelheim International GmbH
$975
Theravance Biopharma, Inc.
$639
OPTOS, INC.
$500
Janssen Pharmaceuticals, Inc
$185
Oculus Surgical Inc.
$161
Harrow Eye, LLC
$72
Rayner Intraocular Lenses Limited
$50
Sun Pharmaceutical Industries Inc.
$40
Janssen Research & Development, LLC
$38
Actelion Pharmaceuticals US, Inc.
$31
Shire North American Group Inc
$24
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
2RT Retinal Rejuvenation Therapy Laser System · 2RT Retinal Rejuvination Therapy Laser System · ARTEVO 800 · AcrySof IQ PanOptix · AcrySof IQ VIVITY · Alcon Greishaber Finesse · AngioVue · BEOVU · BROLUCIZUMAB · BUPARLISIB · BromSite (bromfenac ophthalmic solution) 0.075% · CIRRUS 5000 · CIRRUS HD-OCT · CLARUS · CLARUS 500 · CLARUS 500 Fundus Camera · CLARUS 700 · Centurion · Cimerli · Constellation · DEXTENZA · DEXYCU · DOCTORS ALLERGY FORMULA · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · EYSUVIS · FINESSE SHARKSKIN · FORUM · ILUVIEN · INVELTYS · Izervay · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · Lucentis · Luxor · MIEBO · NGENUITY · Non-Covered Product · None Specified · OCT · OPHTHALMIC INSTRUMENTS · OPMI Lumera 700 · OZURDEX · RETISERT · RTH258A_BEOVU_OPHTHALMOLOGY · RayOne EMV · Rhopressa · Rocklatan · STELLARIS · SUSVIMO · SYFOVRE · Syfovre · TYRVAYA · UPTRAVI · VABYSMO · VISUDYNE · VYZULTA · Vabysmo · VisuMax · XARELTO · XIIDRA · XIPERE · YUTIQ · enVista MX60 IOL
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Boston?
Compare ophthalmologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
518
County median income
$92,859
Nearest hospital to ZIP centroid (approximate)
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Singh performed 68 retinal imaging (oct scan) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $1,660,471 from 48 companies across 1,029 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other ophthalmologists in Boston?
Dr. Singh's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →